S McConnell
Overview
Explore the profile of S McConnell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
907
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eresen A, McConnell S, Birch S, Griffin J, Kornegay J, Ji J
Annu Int Conf IEEE Eng Med Biol Soc
. 2017 Oct;
2017:4066-4069.
PMID: 29060790
Duchenne Muscular Dystrophy (DMD) is a genetic disorder caused by dystrophin protein deficiency. Muscle biopsy is the gold standard to determine the disease severity and progression. MRI has shown potential...
2.
Eresen A, McConnell S, Birch S, Griffin J, Kornegay J, Ji J
Annu Int Conf IEEE Eng Med Biol Soc
. 2017 Mar;
2016:4083-4086.
PMID: 28269180
Duchenne Muscular Dystrophy (DMD) is a fatal X-linked disorder. Therapeutic assessments currently require muscle biopsy to ascertain information about the status of disease progression. MRI shows potential to be used...
3.
McCONVILLE M, Hanna R, Brennan G, Edgar H, McConnell S, McCoy M, et al.
Vet Parasitol
. 2012 Jan;
187(1-2):183-95.
PMID: 22285009
Sheep infected with the triclabendazole-susceptible Cullompton isolate of Fasciola hepatica were treated with compound alpha at a dosage of 15 mg/kg at 12 weeks post-infection. Adult flukes were recovered from...
4.
Hanna R, Scarcella S, Solana H, McConnell S, Fairweather I
Vet Parasitol
. 2011 Sep;
184(2-4):341-7.
PMID: 21944196
Lambs infected with the Cullompton triclabendazole (TCBZ)-susceptible isolate of Fasciola hepatica were treated with TCBZ at a dosage of 10mg/kg at 16 weeks post-infection. Adult flukes were recovered from the...
5.
Scott A, McConnell S, Laird B, Colvin L, Fallon M
Eur J Pain
. 2011 Jun;
16(1):123-33.
PMID: 21658980
Background/aims: Radiotherapy (XRT) is the gold standard treatment for cancer-induced bone pain (CIBP), but only 50% of patients achieve adequate pain relief within 6 weeks. No predictors of analgesic response...
6.
Hanna R, Gordon A, Moffett D, Edgar H, Oliver L, McConnell S, et al.
Vet Parasitol
. 2011 Feb;
178(3-4):251-63.
PMID: 21333449
The efficacies of putative fasciolicides and vaccines against Fasciola hepatica are frequently monitored in clinical and field trials by determination of fluke egg output in host faeces and by worm...
7.
Scarcella S, Fiel C, Guzman M, Alzola R, Felipe A, Hanna R, et al.
Vet Parasitol
. 2010 Dec;
176(2-3):157-64.
PMID: 21167645
The objective of the present study was to analyse the reproductive viability (using histopathologic studies) of Fasciola hepatica from cattle artificially infected and treated subcutaneously with a new experimental formulation...
8.
Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S
Osteoarthritis Cartilage
. 2010 Mar;
18(5):613-20.
PMID: 20188228
Objective: To determine if clinical guidelines recommending therapeutic exercise for people with hip osteoarthritis (OA) are supported by rigorous scientific evidence. Methods: A meta-analysis of randomized controlled trials (RCTs) recruiting...
9.
Hanna R, Edgar H, McConnell S, Toner E, McCONVILLE M, Brennan G, et al.
Vet Parasitol
. 2010 Jan;
168(3-4):240-54.
PMID: 20053501
Twenty-four shed-reared lambs were each infected orally with 250 metacercariae of Fasciola hepatica, using either the triclabendazole (TCBZ)-sensitive Cullompton isolate or the TCBZ-resistant Sligo isolate. Twelve weeks after infection the...
10.
Hanna R, Edgar H, Moffett D, McConnell S, Fairweather I, Brennan G, et al.
Vet Parasitol
. 2008 Sep;
157(3-4):222-34.
PMID: 18774647
A total of 8 calves approximately 6 months old and 22 lambs of similar age were infected with metacercariae of Fasciola hepatica of various laboratory-maintained isolates including: Cullompton (sensitive to...